Register today for the 2024 Cancer Retreat
9 am – Session 1: Plenary
In the plenary session, the event will address learnings from the National Training Day, and the outcomes from the 2024 CTI Board Strategy Day, including the priorities agreed. One of our confirmed speakers will be a major funder of CTI, and we also aim to feature a presentation on a recent submission for PEACEPLUS funding (All-Island initiative).
Speakers to include:
- Eibhlín Mulroe, Cancer Trials Ireland
- Professor Maeve Lowery, TCD & St James’s Hospital
- Angela Clayton-Lea, Cancer Trials Ireland
- Averil Power, Irish Cancer Society
- Deirdre Somers, Chair of the Board, Cancer Trials Ireland
10am – Session 2: Workshop – Learnings from the HRB grant (CTI members only)
Preparations are already beginning for the next HRB Grant cycle, so we wanted to provide an opportunity for members to share their experiences and learnings from the current cycle. CRFs, CRCs and sites will receive a simple template feedback tool in advance of the Retreat. These findings will form the basis of discussion on the day – the aim is to start a collaborative dialogue to inform our approach to the grant. Please note that this session is only open to members of Cancer Trials Ireland.
11.00am – Break
11.20am – Session 3: Panel Discussion – The future of non-drug trials.
After the break, there will be a series of short presentations (5 mins approx.) on Nurse-led research, lifestyle studies, RT Trials, Biobanking, PPI, survivorship and more, all followed by a panel discussion, taking us up to our final session.
Panellists to include :
- Emma Noone, SLRON
- Siobhan Gaynor, Patient Consultants Committee, Cancer Trials Ireland
- Kate O’Connell, UCC & Cork University Hospital
- Others to be confirmed
12.20pm – Session 4: Panel Discussion – CTI in 2030. Panellists to include Professor Donal Brennan, Professor Ronan Cahill and Professor Sinead Brennan
‘What will the future look like, and how will we get there?’. That will be the theme for opening presentations on: the future of surgical studies, AI in trials, Nursing career development, RT, and medical oncology. The purpose of this session is to discuss some of the opportunities and challenges envisaged in the next 5-6 years, to ensure that CTI (as your research network) is positioned to secure all our futures.
Panellists to include :
- Professor Donal Brennan, UCD-GOG
- Professor Ronan Cahill, UCD & Mater Hospital
- Professor Sinead Brennan, IRROG
- Ashley Bazin, TUH
- Others to be confirmed
1pm – Closing Remarks by Professor Seamus O’Reilly, Clinical Lead at Cancer Trials Ireland, followed by a networking lunch.
